Nature Communications (Dec 2023)

Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells

  • Muyesier Maimaitili,
  • Muwan Chen,
  • Fabia Febbraro,
  • Ekin Ucuncu,
  • Rachel Kelly,
  • Jonathan Christos Niclis,
  • Josefine Rågård Christiansen,
  • Noëmie Mermet-Joret,
  • Dragos Niculescu,
  • Johanne Lauritsen,
  • Angelo Iannielli,
  • Ida H. Klæstrup,
  • Uffe Birk Jensen,
  • Per Qvist,
  • Sadegh Nabavi,
  • Vania Broccoli,
  • Anders Nykjær,
  • Marina Romero-Ramos,
  • Mark Denham

DOI
https://doi.org/10.1038/s41467-023-43471-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 23

Abstract

Read online

Abstract Current differentiation protocols for generating mesencephalic dopaminergic (mesDA) neurons from human pluripotent stem cells result in grafts containing only a small proportion of mesDA neurons when transplanted in vivo. In this study, we develop lineage-restricted undifferentiated stem cells (LR-USCs) from pluripotent stem cells, which enhances their potential for differentiating into caudal midbrain floor plate progenitors and mesDA neurons. Using a ventral midbrain protocol, 69% of LR-USCs become bona fide caudal midbrain floor plate progenitors, compared to only 25% of human embryonic stem cells (hESCs). Importantly, LR-USCs generate significantly more mesDA neurons under midbrain and hindbrain conditions in vitro and in vivo. We demonstrate that midbrain-patterned LR-USC progenitors transplanted into 6-hydroxydopamine-lesioned rats restore function in a clinically relevant non-pharmacological behavioral test, whereas midbrain-patterned hESC-derived progenitors do not. This strategy demonstrates how lineage restriction can prevent the development of undesirable lineages and enhance the conditions necessary for mesDA neuron generation.